checkAd

     272  0 Kommentare Theradiag Announces First-half Revenue Up 9%

    Regulatory News:

    THERADIAG (Paris:ALTER) (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, today announced its consolidated first-half revenues for the period ending June 30, 2019.

    in €000

     

    H1 2019

     

    H1 2018

     

    Change

    Revenue*

     

    4,976

     

    4,565

     

    +9%

    of which Theranostics

     

    2,070

     

    1,845

     

    +12%

    of which LISA TRACKER kits in routine use

     

    2,041

     

    1,845

     

    +11%

    of which IVD

     

    2,906

     

    2,720

     

    +7%

    *Figures under audit

     

     

     

     

     

     

    As of 30th June 2019, Theradiag posted first-half revenues of €5.0 million in 2019, up 9% from €4.6 million in H1 2018.

    Theranostics posted a 12% growth, primarily driven by LISA TRACKER kits for routine use, for which sales exceeded €2.0 million in the first half of 2019 (vs. €1.8 million in H1 2018).

    The partnership entered into with IDS during the first half, covering R&D and the exclusive distribution of TRACKER kits in 33 new countries (including Germany, Latin America and the Middle East) is well underway and is progressing according to plan. The development of the next generation of automated technologies is making progress and will allow to speed up the automation of diagnostics. This solution, providing laboratories with greater flexibility and efficiency, will further enhance Theradiag’s competitive advantage. Regarding the marketing of the innovative TRACKER range, training sessions have begun in certain priority regions, and are being rolled-out as planned.

    Seite 1 von 2


    Business Wire (engl.)
    0 Follower
    Autor folgen

    Theradiag Announces First-half Revenue Up 9% Regulatory News: THERADIAG (Paris:ALTER) (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, today announced its consolidated first-half revenues for the period ending June 30, 2019. in €000   H1 …